Azilsartan and Chlorthalidone Tablets
indicated to control blood pressure to manage vascular resistance.
Strengths: 40/12.5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Edarbyclor
- Therapeutic class
Angiotensin II Receptor Antagonist; Thiazide-like diuretic
- Pharmacological class
ARB; Thiazide-like diuretic
- Contraindications
anuria; severe hepatic impairment
- Precautions and warnings
monitor electrolytes and renal function; maintain adequate hydration
- Minor side effects
dizziness; fatigue
- Moderate side effects
hypotension; hyperuricaemia
- Serious side effects
acute renal failure — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
indicated to control blood pressure to manage vascular resistance.
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store below 25°C in the original packaging.
- Drug interactions
lithium; nsaids; potassium-sparing diuretics
- Age restrictions
Not established for children.
Mechanism of action
Combines an angiotensin receptor blocker that blocks the vasoconstrictor effects of angiotensin II with a thiazide-like diuretic that decreases sodium reabsorption, lowering blood pressure.
Pregnancy and breastfeeding
Pregnancy: contraindicated in second and third trimesters. Breastfeeding: not recommended.
Azilsartan and Chlorthalidone Tablets
indicated to control blood pressure to manage vascular resistance.
Editorial Notes
- Active ingredient(s): Azilsartan, Chlorthalidone
- Listed indication(s): Hypertension
Available option
- 90 tablets - 40/12.5 mg1347-40-12-5-mg-16253